Research has found that spending in two areas often maligned for their costs – biopharmaceuticals and public health – account for most of the improvements in life expectancy and patient well-being in the last 20 years. The American Journal of Managed Care and the National Pharmaceutical Council are hosting a webinar on Tuesday, November 10th (5:30 p.m. – 6:30 p.m. ET) to discuss new approaches to balance value, costs, and health improvements.